The Breakthrough


Book Description

Follow along as this New York Times bestselling author details the astonishing scientific discovery of the code to unleashing the human immune system to fight in this "captivating and heartbreaking" book (The Wall Street Journal). For decades, scientists have puzzled over one of medicine's most confounding mysteries: Why doesn't our immune system recognize and fight cancer the way it does other diseases, like the common cold? As it turns out, the answer to that question can be traced to a series of tricks that cancer has developed to turn off normal immune responses -- tricks that scientists have only recently discovered and learned to defeat. The result is what many are calling cancer's "penicillin moment," a revolutionary discovery in our understanding of cancer and how to beat it. In The Breakthrough, New York Times bestselling author of The Good Nurse Charles Graeber guides readers through the revolutionary scientific research bringing immunotherapy out of the realm of the miraculous and into the forefront of twenty-first-century medical science. As advances in the fields of cancer research and the human immune system continue to fuel a therapeutic arms race among biotech and pharmaceutical research centers around the world, the next step -- harnessing the wealth of new information to create modern and more effective patient therapies -- is unfolding at an unprecedented pace, rapidly redefining our relationship with this all-too-human disease. Groundbreaking, riveting, and expertly told, The Breakthrough is the story of the game-changing scientific discoveries that unleash our natural ability to recognize and defeat cancer, as told through the experiences of the patients, physicians, and cancer immunotherapy researchers who are on the front lines. This is the incredible true story of the race to find a cure, a dispatch from the life-changing world of modern oncological science, and a brave new chapter in medical history.




The Coming Cancer Breakthroughs


Book Description

Presents a guide to the most recent developments in cancer treatments, including various clinical trials that are currently available.




Prostate Cancer Breakthroughs


Book Description

Prostate Cancer Breakthroughs 2014 takes you through the entire diagnostic process, answering your questions and suggesting others to ask, then describing 12 different treatment choices for you to consider. Studies have proven that most men diagnosed with prostate cancer do not need surgery or radiation treatment. Find out how to determine whether you do or don't and what your other options are.




Autophagy and Senescence in Cancer Therapy


Book Description

Advances in Cancer Research, Volume 150, the latest release in this ongoing series, covers the relationship(s) between autophagy and senescence, how they are defined, and the influence of these cellular responses on tumor dormancy and disease recurrence. Specific sections in this new release include Autophagy and senescence, converging roles in pathophysiology, Cellular senescence and tumor promotion: role of the unfolded protein response, autophagy and senescence in cancer stem cells, Targeting the stress support network regulated by autophagy and senescence for cancer treatment, Autophagy and PTEN in DNA damage-induced senescence, mTOR as a senescence manipulation target: A forked road, and more. - Addresses the relationship between autophagy and senescence in cancer therapy - Covers autophagy and senescence in tumor dormancy - Explores autophagy and senescence in disease recurrence




Is Cancer Inevitable?


Book Description

"The author, a researcher in oncology, studies the cellular mechanisms of carcinogenesis. In this book written for a popular audience, the author takes a step back from the details of cells to look at the broader issue of how aging affects cancer"--




Tumor Organoids


Book Description

Cancer cell biology research in general, and anti-cancer drug development specifically, still relies on standard cell culture techniques that place the cells in an unnatural environment. As a consequence, growing tumor cells in plastic dishes places a selective pressure that substantially alters their original molecular and phenotypic properties.The emerging field of regenerative medicine has developed bioengineered tissue platforms that can better mimic the structure and cellular heterogeneity of in vivo tissue, and are suitable for tumor bioengineering research. Microengineering technologies have resulted in advanced methods for creating and culturing 3-D human tissue. By encapsulating the respective cell type or combining several cell types to form tissues, these model organs can be viable for longer periods of time and are cultured to develop functional properties similar to native tissues. This approach recapitulates the dynamic role of cell–cell, cell–ECM, and mechanical interactions inside the tumor. Further incorporation of cells representative of the tumor stroma, such as endothelial cells (EC) and tumor fibroblasts, can mimic the in vivo tumor microenvironment. Collectively, bioengineered tumors create an important resource for the in vitro study of tumor growth in 3D including tumor biomechanics and the effects of anti-cancer drugs on 3D tumor tissue. These technologies have the potential to overcome current limitations to genetic and histological tumor classification and development of personalized therapies.







A New Deal for Cancer


Book Description

An unprecedented constellation of experts—leading cancer doctors, policymakers, cutting-edge researchers, national advocates, and more—explore the legacy and the shortcomings from the fifty-year war on cancer and look ahead to the future. The longest war in the modern era, longer than the Cold War, has been the war on cancer. Cancer is a complex, evasive enemy, and there was no quick victory in the fight against it. But the battle has been a monumental test of medical and scientific research and fundraising acumen, as well as a moral and ethical challenge to the entire system of medicine. In A New Deal for Cancer, some of today’s leading thinkers, activists, and medical visionaries describe the many successes in the long war and the ways in which our deeper failings as a society have held us back from a more complete success. Together they present an unrivaled and nearly complete map of the battlefield across dimensions of science, government, equity, business, the patient provider experience, and more, documenting our emerging understanding of cancer’s many unique dimensions and offering bold new plans to enable the American health care system to deliver progress and hope to all patients.




The Truth in Small Doses


Book Description

A decade ago Leaf, a cancer survivor himself, began to investigate why we had made such limited progress fighting this terrifying disease. The result is a gripping narrative that reveals why the public's immense investment in research has been badly misspent, why scientists seldom collaborate and share their data, why new drugs are so expensive yet routinely fail, and why our best hope for progress-- brilliant young scientists-- are now abandoning the search for a cure.




The Great Secret: The Classified World War II Disaster that Launched the War on Cancer


Book Description

The gripping story of a chemical weapons catastrophe, the cover-up, and how one American Army doctor’s discovery led to the development of the first drug to combat cancer, known today as chemotherapy. On the night of December 2, 1943, the Luftwaffe bombed a critical Allied port in Bari, Italy, sinking seventeen ships and killing over a thousand servicemen and hundreds of civilians. Caught in the surprise air raid was the John Harvey, an American Liberty ship carrying a top-secret cargo of 2,000 mustard bombs to be used in retaliation if the Germans resorted to gas warfare. When one young sailor after another began suddenly dying of mysterious symptoms, Lieutenant Colonel Stewart Alexander, a doctor and chemical weapons expert, was dispatched to investigate. He quickly diagnosed mustard gas exposure, but was overruled by British officials determined to cover up the presence of poison gas in the devastating naval disaster, which the press dubbed "little Pearl Harbor." Prime Minister Winston Churchill and General Dwight D. Eisenhower acted in concert to suppress the truth, insisting the censorship was necessitated by military security. Alexander defied British port officials and heroically persevered in his investigation. His final report on the Bari casualties was immediately classified, but not before his breakthrough observations about the toxic effects of mustard on white blood cells caught the attention of Colonel Cornelius P. Rhoads—a pioneering physician and research scientist as brilliant as he was arrogant and self-destructive—who recognized that the poison was both a killer and a cure, and ushered in a new era of cancer research led by the Sloan Kettering Institute. Meanwhile, the Bari incident remained cloaked in military secrecy, resulting in lost records, misinformation, and considerable confusion about how a deadly chemical weapon came to be tamed for medical use. Deeply researched and beautifully written, The Great Secret is the remarkable story of how horrific tragedy gave birth to medical triumph.